MACC1 – a novel target for solid cancers

Bibliography

• Stein U, Schlag PM. Clinical, biological, and molecular aspects of metastasis in colorectal cancer. Recent Results Cancer Res 2007;176:61-80
   PubMedGoogle Scholar
• Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: globocan 2008. Int J Cancer 2010;127:2893-917
   PubMed Web of Science ®Google Scholar
• Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013;63:11-30
   PubMedGoogle Scholar
• Etzioni R, Urban N, Ramsey S, et al. The case for early detection. Nat Rev Cancer 2003;3:243-52
   PubMed Web of Science ®Google Scholar
• Sethi N, Kang Y. Unravelling the complexity of metastasis - molecular understanding and targeted therapies. Nat Rev Cancer 2011;11:735-48
   PubMed Web of Science ®Google Scholar
• Wanebo HJ, LeGolvan M, Paty PB, et al. Meeting the biologic challenge of colorectal metastases. Clin Exp Metastasis 2012;29:821-39
   PubMedGoogle Scholar
• Stein U, Walther W, Arlt F, et al. MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis. Nat Med 2009;15:59-67
   PubMed Web of Science ®Google Scholar
• Juneja M, Ilm K, Schlag PM, et al. Promoter identification and transcriptional regulation of the metastasis gene MACC1 in colorectal cancer. Mol Oncol 2013; doi: 10.1016/j.molonc.2013.05.003
   PubMedGoogle Scholar
• Stein U, Smith J, Walther W, et al. MACC1 controls Met: what a difference an Sp1 site makes. Cell Cycle 2009;8:2467-9
   PubMed Web of Science ®Google Scholar
• Gherardi E, Birchmeier W, Birchmeier C, et al. Targeting MET in cancer: rationale and progress. Nat Rev Cancer 2012;12:89-103
   PubMed Web of Science ®Google Scholar
• Lemos C, Sack U, Schmid F, et al. Anti-metastatic treatment in colorectal cancer: targeting signaling pathways. Curr Pharm Des 2012;19:841-63
   Google Scholar
• Luraghi P, Schelter F, Krüger A, et al. The MET oncogene as a therapeutical target in cancer invasive growth. Front Pharmacol 2012;3:164
   PubMedGoogle Scholar
• Raghav KPS, Eng C. Role of the MET-HGF axis in colorectal cancer: precepts and prospects. Colorectal Cancer 2012;1:329-41
   Google Scholar
• Arlt F, Stein U. Colon cancer metastasis: MACC1 and Met as metastatic pacemakers. Int J Biochem Cell Biol 2009;41:2356-9
   PubMed Web of Science ®Google Scholar
• Schmid F, Wang Q, Huska M, et al. SPON2, a newly identified transcriptional target gene of MACC1, is associated with colorectal cancer metastasis. Eur J Cancer 2012;48(Suppl 6):63-4
   Google Scholar
• Schmid F, Wang Q, Huska MR, et al. S100P, a target gene of MACC1, contributes to colorectal cancer metastasis. Proc Am Ass Cancer Res 2013;54:416
   Google Scholar
• Tokarz P, Blasiak J. The role of microRNA in metastatic colorectal cancer and its significance in cancer prognosis and treatment. Acta Biochim Pol 2012;59:467-74
   PubMed Web of Science ®Google Scholar
• Migliore C, Martin V, Leoni VP, et al. MiR-1 downregulation cooperates with MACC1 in promoting MET overexpression in human colon cancer. Clin Cancer Res 2012;18:737-47
   PubMedGoogle Scholar
• Zhang Y, Wang Z, Chen M, et al. MicroRNA-143 targets MACC1 to inhibit cell invasion and migration in colorectal cancer. Mol Cancer 2012;11:23
   PubMed Web of Science ®Google Scholar
• Chen J, Wang B. The role of miRNA-143 in colon cancer and therapeutic implications. Transl Gastrointest Cancer 2012;1:169-74
   Google Scholar
• Kokoszyńska K, Kryński J. Rychlewski L, et al. Unexpected domain composition of MACC1 links MET signaling and apoptosis. Acta Biochim Pol 2009;56:317-23
   PubMedGoogle Scholar
• Stein U, Dahlmann M, Walther W. MACC1 - more than metastasis? Facts and predictions about a novel gene. J Mol Med 2010;88:11-18
   PubMedGoogle Scholar
• Voss M, Lettau M, Janssen O. Identification of SH3 domain interaction partners of human FasL (CD178) by phage display screening. BMC Immunol 2009;10:53
   PubMedGoogle Scholar
• Greening DW, Kapp EA, Ji H, et al. Colon tumour secretopeptidome: insights into endogenous proteolytic cleavage events in the colon tumour microenvironment. Biochim Biophys Acta 2013; [Epub ahead of print]
   Google Scholar
• Pichorner A, Sack U, Kobelt D, et al. In vivo imaging of colorectal cancer growth and metastasis by targeting MACC1 with shRNA in xenografted mice. Clin Exp Metastasis 2012;29:573-83
   PubMedGoogle Scholar
• Choi DS, Choi DY, Hong BS, et al. Quantitative proteomics of extracellular vesicles derived from human primary and metastatic colorectal cancer cells. J Extracellular Vesicles 2012;1:18704
   PubMedGoogle Scholar
• Zhang Y, Wang Z. The influence of MACC1 on liver metastasis from colon cancer cells. Tumor 2011;31:513-16
   Google Scholar
• Galimi F, Torti D, Sassi F, et al. Genetic and expression analysis of MET, MACC1, and HGF in metastatic colorectal cancer: response to met inhibition in patient xenografts and pathologic correlations. Clin Cancer Res 2011;17:3146-56
   PubMed Web of Science ®Google Scholar
• Loo LW, Tiirikainen M, Cheng I, et al. Integrated analysis of genome-wide copy number alterations and gene expression in microsatellite stable, CpG island methylator phenotype negative colon cancer. Genes Chromosomes Cancer 2013;52:450-66
   PubMedGoogle Scholar
• Shirahata A, Shinmura K, Kitamura Y, et al. MACC1 as a marker for advanced colorectal carcinoma. Anticancer Res 2010;30:2689-92
   PubMed Web of Science ®Google Scholar
• Ashktorab H, Herrmann P, Razjouan H, et al. MACC1 expression as molecular marker in colorectal cancer. Proc Am Ass Cancer Res 2011;52:927
   Google Scholar
• Isella C, Mellano A, Galimi F, et al. MACC1 mRNA levels predict cancer recurrence after resection of colorectal cancer liver metastases. Ann Surg 2013;257:1089-95
   PubMedGoogle Scholar
• Boardman LA. Overexpression of MACC1 leads to downstream activation of HGF/MET and potentiates metastasis and recurrence of colorectal cancer. Genome Med 2009;1:36
   PubMedGoogle Scholar
• LeGolvan MP, Resnick M. Pathobiology of colorectal cancer hepatic metastases with an emphasis on prognostic factors. J Surg Oncol 2010;102:898-908
   PubMed Web of Science ®Google Scholar
• Zlobec I. Novel biomarkers for the prediction of metastasis in colorectal cancer. Expert Opin Med Diagn 2013;7:137-46
   PubMedGoogle Scholar
• Nitsche U, Rosenberg R, Balmert A, et al. Integrative marker analysis allows risk assessment for metastasis in stage II colon cancer. Ann Surg 2012;256:763-71
   PubMed Web of Science ®Google Scholar
• Reece-Smith A, Argent R, Onio D, et al. The role of epithelial to mesenchymal transitions (MET) in the establishment of colorectal liver metastases. A potential source of prognostic biomarkers. Br J Surgery 2010;97:S5
   Google Scholar
• Kennedy RD, Bylesjo M, Kerr P, et al. Development and independent validation of a prognostic assay for stage II colon cancer using formalin-fixed paraffin-embedded tissue. J Clin Oncol 2011;29:4620-6
   PubMed Web of Science ®Google Scholar
• Wiśniewski JR, Ostasiewicz P, Mann M. High recovery FASP applied to the proteomic analysis of microdissected formalin fixed paraffin embedded cancer tissues retrieves known colon cancer markers. J Proteome Res 2011;10:3040-9
   PubMed Web of Science ®Google Scholar
• Merlos-Suárez A, Barriga FM, Jung P, et al. The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse. Cell Stem Cell 2011;8:511-24
   PubMed Web of Science ®Google Scholar
• Kawamura M, Saigusa S, Toiyama Y, et al. Correlation of MACC1 and MET expression in rectal cancer after neoadjuvant chemoradiotherapy. Anticancer Res 2012;32:1527-31
   PubMed Web of Science ®Google Scholar
• Stein U, Burock S, Herrmann P, et al. Circulating MACC1 transcripts in colorectal cancer patient plasma predict metastasis and prognosis. PLoS One 2012;7:e49249
   PubMedGoogle Scholar
• Toiyama Y, Miki C, Inoue Y, et al. Serum hepatocyte growth factor as a prognostic marker for stage II or III colorectal cancer patients. Int J Cancer 2009;125:1657-62
   PubMed Web of Science ®Google Scholar
• Lang AH, Geller-Rhomberg S, Winder T, et al. A common variant of the MACC1 gene is significantly associated with overall survival in colorectal cancer patients. BMC Cancer 2012;12:20
   PubMedGoogle Scholar
• Lang S, Geller-Rhomberg T, Winder BL, et al. Evaluation of the association between tagging polymorphisms of the MACC1 locus and overall survival in patients with colorectal cancer. ACSO Meeting. J Clin Oncol 2011;29(Suppl):abstracts 3594
   Google Scholar
• Schmid F, Burock S, Klockmeier K, et al. SNPs in the coding region of the metastasis-inducing gene MACC1 and clinical outcome in colorectal cancer. Mol Cancer 2012;11:49
   PubMedGoogle Scholar
• Shirahata A, Sakata M, Kitamura Y, et al. MACC 1 as a marker for peritoneal-disseminated gastric carcinoma. Anticancer Res 2010;30:3441-4
   PubMed Web of Science ®Google Scholar
• Wang L, Wu Y, Lin L, et al. MACC1 upregulation predicts a poor prognosis of gastric cancer, and promotes tumor cell proliferation and invasion. Int J Cancer 2013; [Epub ahead of print]
   Google Scholar
• Wang N, Xie JM, Zheng DY, et al. Establishment of BGC-823/pBaBb-puro-MACC1 gastric cancer cell line stably expressing MACC1 and its tumor-related gene expression profiles. Nan Fang Yi Ke Da Xue Xue Bao 2012;32:312-16
   PubMedGoogle Scholar
• Ge SH, Wu XJ, Wang XH, et al. Over-expression of metastasis-associated in colon cancer-1 (MACC1) associates with better prognosis of gastric cancer patients. Chin J Cancer Res 2011;23:153-9
   PubMedGoogle Scholar
• Wang G, Kang MX, Lu WJ, et al. MACC1: a potential molecule associated with pancreatic cancer metastasis and chemoresistance. Oncol Lett 2012;4:783-91
   PubMedGoogle Scholar
• Stein U, Herrmann P, Fischer C, et al. Circulating MACC1 transcripts are elevated in pancreatic cancer patient blood and correlate to locally advanced disease. Proc Am Ass Cancer Res 2013;54:5106
   Google Scholar
• Shirahata A, Fan W, Sakuraba K, et al. MACC 1 as a marker for vascular invasive hepatocellular carcinoma. Anticancer Res 2011;31:777-80
   PubMed Web of Science ®Google Scholar
• Qiu J, Huang P, Liu Q, et al. Identification of MACC1 as a novel prognostic marker in hepatocellular carcinoma. J Transl Med 2011;9:166
   PubMedGoogle Scholar
• Qu JH, Chang XJ, Lu YY, et al. Overexpression of metastasis-associated in colon cancer 1 predicts a poor outcome of hepatitis B virus-related hepatocellular carcinoma. World J Gastroenterol 2012;18:2995-3003
   PubMed Web of Science ®Google Scholar
• Gao J, Ding F, Liu Q, et al. Knockdown of MACC1 expression suppressed hepatocellular carcinoma cell migration and invasion and inhibited expression of MMP2 and MMP9. Mol Cell Biochem 2013;376:21-32
   PubMedGoogle Scholar
• Xie C, Wu J, Yun J, et al. MACC1 as a prognostic biomarker for early-stage and AFP-normal hepatocellular carcinoma. PLoS One 2013;8:e64235
   PubMedGoogle Scholar
• Yang YP, Qu JH, Chang XJ, et al. High intratumoral metastasis-associated in colon cancer-1 expression predicts poor outcomes of cryoablation therapy for advanced hepatocellular carcinoma. J Transl Med 2013;11:41
   PubMed Web of Science ®Google Scholar
• Subrungruang I, Thawornkuno T, Chawalitchewinkoon-Petmitr R, et al. Gene expression profiling of intrahepatic cholangiocarcinoma. Asian Pacific J Cancer Prevention 2013;14:557-63
   PubMedGoogle Scholar
• Shimokawa H, Uramoto H, Onitsuka T, et al. Overexpression of MACC1 mRNA in lung adenocarcinoma is associated with postoperative recurrence. J Thorac Cardiovasc Surg 2011;141:895-8
   PubMedGoogle Scholar
• Chundong G, Uramoto H, Onitsuka T, et al. Molecular diagnosis of MACC1 status in lung adenocarcinoma by immunohistochemical analysis. Anticancer Res 2011;31:1141-5
   PubMedGoogle Scholar
• Hu X, Fu X, Wen S, et al. Prognostic value of MACC1 and c-met expressions in non-small cell lung cancer. Zhongguo Fei Ai Za Zhi 2012;15:399-403
   PubMedGoogle Scholar
• Saintigny P, Zhang L, Girard L, et al. Use of an EGFR mutation signature to estimate prognosis in EGFR wild-type lung adenocarcinomas and identify metastasis associated in colon cancer 1 (MACC1) as a regulator of MET [abstract 121]. ASCO Meeting Molecular Markers; 2010
   Google Scholar
• Zhang R, Shi H, Chen Z, et al. Effects of metastasis-associated in colon cancer 1 inhibition by small hairpin RNA on ovarian carcinoma OVCAR-3 cells. J Exp Clin Cancer Res 2011;30:83
   PubMed Web of Science ®Google Scholar
• Huang H, Shi H, Zhang R, et al. Expr`ssion of MACC1 in epithelial ovarian cancer and its clinical significance. Tumor 2011;31:522-6
   Google Scholar
• Huang Y, Zhang H, Cai J, et al. Overexpression of MACC1 and its significance in human breast cancer progression. Cell Biosci 2013;3:16
   PubMedGoogle Scholar
• Leth-Larsen R, Terp MG, Christensen AG, et al. Functional heterogeneity within the CD44 high human breast cancer stem cell-like compartment reveals a gene signature predictive of distant metastasis. Mol Med 2012;18:1109-21
   PubMed Web of Science ®Google Scholar
• Stein U, Fuchs S, Monoranu CM, et al. MACC1 expression as biomarker for progression and prognosis of human malignant glioma. Proc Am Ass Cancer Res 2012;53:107
   Google Scholar
• Yang TH, Kon M, Hung JH, DeLisi C. Combinations of newly confirmed glioma-associated loci link regions on chromosomes 1 and 9 to increased disease risk. BMC Med Genomics 2011;4:63
   PubMedGoogle Scholar
• Amlin-Van Schaick JC, Kim S, DiFabio C, et al. Arlm1 is a male-specific modifier of astrocytoma resistance on mouse Chr 12. Neuro Oncol 2012;14:160-74
   PubMed Web of Science ®Google Scholar
• Meng F, Li H, Shi H, et al. MACC1 down-regulation inhibits proliferation and tumourigenicity of nasopharyngeal carcinoma cells through Akt/β-catenin signaling pathway. PLoS One 2013;8:e60821
   PubMed Web of Science ®Google Scholar
• Shang C, Zhang H, Song Y. MACC1 gene and kidney cancer metastasis and its effect on cell invasion. Modern Oncol 2011;4:637-9
   Google Scholar
• Shang C, Zhang H, Song Y-S. Regulation between MACC1 and c-Met in proliferative process of renal carcinoma. Chin J Cancer Prevention Treatment 2011;18:1065-7 +87
   Google Scholar
• Becker H, Marcucci G, Maharry K, et al. Mutations of the Wilms tumor 1 gene (WT1) in older patients with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study. Blood 2010;116:788–92
   PubMed Web of Science ®Google Scholar
• Zhu M, Xu Y, Mao X, et al. Overexpression of metastasis-associated in colon cancer-1 associated with poor prognosis in patients with esophageal cancer. Pathol Oncol Res 2013; [Epub ahead of print]
   Google Scholar
• Grivennikov SI. Inflammation and colorectal cancer: colitis-associated neoplasia. Semin Immunopathol 2013;35:229-44
   PubMed Web of Science ®Google Scholar
• Elding H, Lau W, Swallow DM, et al. Refinement in localization and identification of gene regions associated with crohn disease. Am J Hum Genet 2013;92:107-13
   PubMed Web of Science ®Google Scholar
• El Chartouni C, Rehli M. Comprehensive analysis of TLR4-induced transcriptional responses in interleukin 4-primed mouse macrophages. Immunobiology 2010;215:780-7
   PubMedGoogle Scholar
• Ali G, Lee K, Andrade PB, et al. Novel autosomal recessive nonsyndromic hearing impairment locus DFNB90 maps to 7p22.1-p15.3. Hum Hered 2011;71:106-12
   PubMedGoogle Scholar
• Khanobdee K, Kolberg JB, Dunlevy JR. Nuclear and plasma membrane localization of SH3BP4 in retinal pigment epithelial cells. Mol Vis 2004;10:933-42
   PubMedGoogle Scholar
• Dunlevy JR, Koppelman ED, Kolberg JB. The expression of a SH3BP4-related protein in retinal cells. Invest Ophthalmol Vis Sci 2005;46:2996
   Google Scholar
• Yin J, Shine L, Raycroft F, et al. Inhibition of the Pim1 oncogene results in diminished visual function. PLoS ONE 2012;7:e52177
   PubMedGoogle Scholar
• Melvin VS, Feng W, Hernandez-Lagunas L, et al. A morpholino-based screen to identify novel genes involved in craniofacial morphogenesis. Dev Dyn 2013; [Epub ahead of print]
   PubMedGoogle Scholar
• Lin M, Pedrosa E, Shah A, et al. RNA-Seq of human neurons derived from iPS cells reveals candidate long non-coding rnas involved in neurogenesis and neuropsychiatric disorders. PLoS ONE 2011;6:e23356
   PubMed Web of Science ®Google Scholar
• Ligthart L, de Vries B, Smith AV, et al. Meta-analysis of genome-wide association for migraine in six population-based European cohorts. Eur J Hum Genet 2011;19:901-7
   PubMed Web of Science ®Google Scholar
• Hager J, Kamatani Y, Cazier JB, et al. the FGENTCARD Consortium. Genome-wide association study in a lebanese cohort confirms PHACTR1 as a major determinant of coronary artery stenosis. PLoS One 2012;7:e38663
   PubMedGoogle Scholar